Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Controversias en la Investigación Clínica. Estudios específicos de Raza y el caso BIDIL
Controversies in Clinical Research. Race-Specific Studies and the BiDil Case
DOI:
https://doi.org/10.15446/ideasyvalores.v71n8Supl.103586Palabras clave:
BiDil, ciencia y valores, controversias científicas, estudios específicos de raza (es)BiDil, science and values, scientific controversies, race specific studies (en)
Descargas
El objetivo principal de este artículo es analizar los estudios que respaldan la aprobación y el uso del BiDil, el primer medicamento aprobado para uso exclusivo en población afroamericana en EE. UU., así como la controversia que surgió alrededor de este. En particular, mostraré que la controversia sobre el BiDil no debe entenderse como una controversia puramente epistémica, sino como una controversia compleja en la que convergen aspectos tanto epistémicos como ético-sociales y comerciales. Entender cómo están interrelacionados estos aspectos y qué conocimiento podemos obtener dada la complejidad de estas interacciones resulta crucial para comprender la controversia sobre el BiDil, así como otras controversias científicas actuales.
This article aims to analyze the clinical studies that support the approval and use of BiDil, the first drug approved for exclusive use in African-Americans, as well as the controversy surrounding this drug. In particular, my aim is to show that the controversy over BiDil should not be understood as purely epistemic, but rather as a complex controversy in which epistemic, ethical, and commercial aspects converge. Understanding how these aspects are interrelated and what knowledge is available to us given the complexity of such interrelations is crucial for understanding the BiDil controversy, as well as other scientific controversies today.
Referencias
Allchin, Douglas. “Values in Science: An Educational Perspective.” Science & Education 8 (1999): 1-12. [https://doi.org/10.1023/A:1008600230536] DOI: https://doi.org/10.1023/A:1008600230536
Anderson, Elizabeth. “Uses of Value Judgments in Science: A General Argument, with Lessons from a Case Study of Feminist Research on Divorce.” Hypatia 19 (2004): 1-24. [https://doi.org/10.1111/j.1527-2001.2004.tb01266.x] DOI: https://doi.org/10.1111/j.1527-2001.2004.tb01266.x
Ball, Catherine et al. “Genetic Communities™ White Paper: Predicting fine-scale ancestral origins from the genetic sharing patterns among millions of individuals.” Ancestry. [https://www.ancestry.com/cs/dna-help/communities/whitepaper]
Bigos, Kristin L., Bruce Pollock, Beth Stankevich, Rober Bies. “Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review.” Gender Medicine 6.4 (2009): 522-543. [https://doi.org/10.1016/j.genm.2009.12.004] DOI: https://doi.org/10.1016/j.genm.2009.12.004
Bloche, M. Gregg. “Race-Based Therapeutics.” The New England Journal of Medicine 351.20 (2004): 2035-37. DOI: https://doi.org/10.1056/NEJMp048271
Broadbent, Alex. “Inferring Causation in Epidemiology: Mechanisms, Black Boxes, and Contrasts. Causality in the Sciences. Edited by Illari Mckay and Federica Russo, 2011. 45-69. [http://www.hps.cam.ac.uk/people/broadbent/epidemiology_mechanisms_ inference.pdf] DOI: https://doi.org/10.1093/acprof:oso/9780199574131.003.0003
Brown, Matthew. “Values in Science beyond Underdetermination and Inductive Risk.” Philosophy of Science 80.5 (2013): 829-839. DOI: https://doi.org/10.1086/673720
Carson, Peter et al. “Racial Differences in Response to Therapy for Heart Failure: Analysis of the Vasodilator-Heart Failure Trials.” Journal of Cardiac Failure 5.3 (1999): 178-187. [https://doi.org/10.1016/S1071-9164(99)90001-5]. DOI: https://doi.org/10.1016/S1071-9164(99)90001-5
Cruickshank, J K, and D G Beevers. “Epidemiology of hypertension: blood pressure in blacks and whites.” 62.1 (1982): 1-6. [https://doi.org/10.1042/cs0620001] DOI: https://doi.org/10.1042/cs0620001
De Melo-Martín, Inmaculada and Intemann, Kristen. The Fight Against Doubt: How to Bridge the Gap Between Scientists and the Public. Oxford University Press, 2018. DOI: https://doi.org/10.1093/oso/9780190869229.001.0001
Dirks, N L et al. “Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.” International journal of clinical pharmacology and therapeutics 42.12 (2004): 701-718. [https://doi.org/10.5414/cpp42701] DOI: https://doi.org/10.5414/CPP42701
Douglas, Heather E. Science, Policy, and the Value-Free Ideal. University of Pittsburgh, 2009. DOI: https://doi.org/10.2307/j.ctt6wrc78
Dries, Daniel L. et al. “Racial Differences in the Outcome of Left Ventricular Dysfunction.” New England Journal of Medicine 340. 8 (1999): 609-616. [http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10029645]. DOI: https://doi.org/10.1056/NEJM199902253400804
Epstein, Steven. Inclusion: The Politics of Difference in Medical Research. The University of Chicago Press, 2007. DOI: https://doi.org/10.7208/chicago/9780226213118.001.0001
Fernández Pinto, Manuela. “Democratizing Strategies for Industry-Funded Medical Research: A Cautionary Tale.” Philosophy of Science 85.5 (2018): 882-94. [https:// doi.org/10.1086/699720] DOI: https://doi.org/10.1086/699720
Fernández Pinto, Manuela. “Philosophy of Science for Globalized Privatization. Uncovering Some Limitations of Critical Contextual Empiricism.” Studies in History and Philosophy of Science Part A 47 (2014): 10-17. [https://doi.org/10.1016/j. shpsa.2014.03.006] DOI: https://doi.org/10.1016/j.shpsa.2014.03.006
Franciosa, Joseph A. et al. “African-American Heart Failure Trial (a-heft): Rationale, Design, and Methodology.” Journal of Cardiac Failure 8.3 (2002): 128-135. [https:// doi.org/10.1054/jcaf.2002.124730] DOI: https://doi.org/10.1054/jcaf.2002.124730
Frohlich, Edward D. “Left ventricular hypertrophy: a major factor of risk in Black hypertensive patients.” American journal of hypertension 27.1 (2014): 1-2. [https://doi. org/10.1093/ajh/hpt214] DOI: https://doi.org/10.1093/ajh/hpt214
Fuentes, Agustín. Race, Monogamy, and Other Lies They Told You. University of California Press, 2012. DOI: https://doi.org/10.1525/9780520951679
Grasswick, Heidi. E. “Feminist Epistemology and Philosophy of Science.” Feminist Philosophy Collection, 2011. [https://doi.org/10.1007/978-1-4020-6835-5] DOI: https://doi.org/10.1007/978-1-4020-6835-5
Hempel, Carl. Aspects of Scientific Explanation. Free Press, 1965.
Henig, Robin Marantz. “The Genome in Black and White (and Gray).” New York Times (1923-Current File), 2004. sm46, [http://proquest.umi.com/pqdweb?did=107166399 2&Fmt=7&clientId=48051&RQT=309&VName=HNP]
Holman, Bennett y Kevin C. Elliott. “The Promise and Perils of Industry-Funded Science.” Philosophy Compass 13.11 (2018): 1-14. [https://doi.org/10.1111/phc3.12544] DOI: https://doi.org/10.1111/phc3.12544
Howard, George et al. “Racial and Geographic Differences in Awareness, Treatment, and Control of Hypertension.” Stroke 37.5 (2006): 1171-1178. [https://doi.org/10.1161/01. STR.0000217222.09978.ce] DOI: https://doi.org/10.1161/01.STR.0000217222.09978.ce
Kahn, Jonathan. “How a Drug Becomes Ethnic: Law, Commerce, and the Production of Racial Categories in Medicine.” Yale Journal of Health Policy, Law, and Ethics 4.1 (2004): 1-46. [http://digitalcommons.law.yale.edu/yjhple%0A http://digitalcommons. law.yale.edu/yjhple/vol4/iss1/1]
Krieger, Nancy et al. “Racism, sexism, and social class: implications for studies of health, disease, and well-being.” American Journal of Preventive Medicine 9.6 (1993): 82-122. DOI: https://doi.org/10.1016/S0749-3797(18)30666-4
Kuhn, Thomas. The Essential Tension. The University of Chicago Press, 1977. DOI: https://doi.org/10.7208/chicago/9780226217239.001.0001
Longino, Helen E. “Gender, Politics, and the Theoretical Virtues.” Synthese 104.3 (1995): 383-397. [https://doi.org/10.1007/BF01064506] DOI: https://doi.org/10.1007/BF01064506
McMullin, Ernan. “Scientific Controversy and Its Termination.” Scientific Controversies: Case Studies in the Resolution and Closure of Disputes in Science and Technology. Edited by H. Tristram Engelhardt and Arthur Caplan. 1987. 49-91. Cambridge University Press. DOI: https://doi.org/10.1017/CBO9780511628719.004
Moser, Marvin and Lunn, Jhon. “Responses to captopril and hydrochlorothiazide in black patients with hypertension.” Clinical pharmacology and therapeutics. 32.3 (1982): 307-312. [https://doi.org/10.1038/clpt.1982.165] DOI: https://doi.org/10.1038/clpt.1982.165
Neurath, Otto. “The Lost Wanderers of Descartes and the Auxiliary Motive.” Philosophical Papers 1913-1946. 2011. 1-12. [https://doi.org/10.1007/978-94-009-6995-7_1] DOI: https://doi.org/10.1007/978-94-009-6995-7_1
Pollock, Anne. Medicating Race. Duke University Press, 2012. [https://doi.org/10.1215/ 9780822395782] DOI: https://doi.org/10.2307/j.ctv11hpmb0
Ramasubbu, Kumudha; Gurm, Hitinder, and Litaker, David.“Gender Bias in Clinical Trials: Do Double Standards Still Apply?” Journal of Women’s Health & Gender-Based Medicine 10.8 (2002): 757-64. [https://doi.org/10.1089/15246090152636514] DOI: https://doi.org/10.1089/15246090152636514
Rosenberg, Noah A et al. “Genetic structure of human populations.” Science 298.5602 (2002): 2381-5. [https://doi.org/10.1038/s41598-020-80389-9] DOI: https://doi.org/10.1126/science.1078311
Rudner, Richard. “The Scientist qua Scientist Makes Value Judgments.” Philosophy of Science 20.1 (1953): 1-6. [https://psycnet.apa.org/doi/10.1086/287231] DOI: https://doi.org/10.1086/287231
Schwartz, Robert. “Racial Profiling in Medical Research.” New England Journal of Medicine 344.18 (2001): 1392-93. DOI: https://doi.org/10.1056/NEJM200105033441810
Sismondo, Sergio. Ghost-Managed Medicine: Big Pharma’s Invisible Hands. Mattering Press, 2018. DOI: https://doi.org/10.28938/9780995527775
Solomon, Miriam. Social Empiricism. Massachusetts Institute of Technology Press, 2001. DOI: https://doi.org/10.7551/mitpress/6296.001.0001
Taylor, Anne L. et al. “Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure.” New England Journal of Medicine 351.20 (2004): 2049-2058. [https://doi.org/10.1056/NEJMoa042934] DOI: https://doi.org/10.1056/NEJMoa042934
Taylor, Holly A. “Inclusion of women, minorities, and children in clinical trials: opinions of research ethics board administrators.” Journal of empirical research on human research ethics: 4.2 (2009): 65-73. [https://doi.org/10.1525/jer.2009.4.2.65] DOI: https://doi.org/10.1525/jer.2009.4.2.65
Tseng, Jennifer E., et al. “Advances in Brief Gender Differences in P53 Mutational Status in Small Cell Lung Cancer 1.” Lung Cancer. 1999. 5666–70.
Valles, Sean A. “Heterogeneity of Risk within Racial Groups, a Challenge for Public Health Programs.” Preventive Medicine 55.5 (2012): 405-408. [https://doi.org/10.1016/j.ypmed.2012.08.022] DOI: https://doi.org/10.1016/j.ypmed.2012.08.022
Cómo citar
MODERN-LANGUAGE-ASSOCIATION
ACM
ACS
APA
ABNT
Chicago
Harvard
IEEE
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2022 Los derechos son del autor(es), quien(es) puede re-publicar en parte o en su totalidad el documento ya publicado en la revista siempre y cuando se dé el debido reconocimiento a Ideas y Valores
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
De acuerdo con la Licencia Creative Commons Atribución-No Comercial-SinDerivar 4.0 Internacional. Se autoriza copiar, redistribuir el material en cualquier medio o formato, siempre y cuando se conceda el crédito a los autores de los textos y a Ideas y Valores como fuente de publicación original. No se permite el uso comercial de copia o distribución de contenidos, así como tampoco la adaptación, derivación o transformación alguna de estos sin la autorización previa de los autores y de la dirección de Ideas y Valores. Para mayor información sobre los términos de esta licencia puede consultar: http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.
.jpg)
